Metraipolis › archive › dc_c7107987d295

ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41939918
DOI
10.3389/fimmu.2026.1800533
License (as archived)
solo-consultazione
Archived
2026-11-04T05:22:42.328Z
SHA-256 of the archived text
439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6
Stable URL of this page
https://metraipolis.com/documento/dc_c7107987d295

How to cite

ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918 — Europe PMC (en), https://europepmc.org/article/MED/41939918 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7107987d295 (Metraipolis archive dc_c7107987d295, sha256 439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6)
BibTeX
@misc{dcc7107987d295,
  title = {ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma — Europe PMC PMID:41939918},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939918},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7107987d295; sha256 439cad9f77d6a4db720cefae8683dd3888c600b69fd30698942929a55fa051c6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939918. Agents can read the archived copy with the MCP tool read_document.